Hepatocellular carcinoma: measures to improve the outlook in sub-Saharan Africa
- 8 July 2022
- journal article
- research article
- Published by Elsevier in The Lancet Gastroenterology & Hepatology
- Vol. 7 (11) , 1036-1048
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- GlaxoSmithKline
- Gilead Sciences
This publication has 106 references indexed in Scilit:
- Association of Early Age at Establishment of Chronic Hepatitis B Infection with Persistent Viral Replication, Liver Cirrhosis and Hepatocellular Carcinoma: A Systematic ReviewPLOS ONE, 2013
- Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up studyThe Lancet, 2013
- Aflatoxin B1-induced hepatocellular carcinoma in developing countries: Geographical distribution, mechanism of action and preventionOncology Letters, 2013
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicitiesHepatology, 2010
- Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography†Hepatology, 2009
- Association between hepatitis C and hepatocellular carcinomaJournal of Global Infectious Diseases, 2009
- Occult hepatitis B virus infection in Southern African blacks with hepatocellular carcinomaJournal of Gastroenterology and Hepatology, 2008
- Increased hepatocarcinogenic potential of hepatitis B virus genotype A in Bantu‐speaking sub‐saharan AfricansJournal of Medical Virology, 2005
- Dietary iron overload as a risk factor for hepatocellular carcinoma in black africansHepatology, 1998